News Focus
News Focus
Followers 8
Posts 907
Boards Moderated 0
Alias Born 10/01/2020

Re: exwannabe post# 804162

Monday, 12/22/2025 10:03:56 AM

Monday, December 22, 2025 10:03:56 AM

Post# of 817835
Seems like that's correct, that NWBO don't own Revimmune.

However, they are both on a patent as per below.


Patents Assigned to Northwest Biotherapeutics, Inc.

COMBINATIONS OF CHECKPOINT INHIBITORS AND THERAPEUTICS TO TREAT CANCER
Publication number: 20240382572
Abstract: The present disclosure arises at least in part from the seminal recognition that a combination treatment regimen including one or more cycles and/or doses of a checkpoint inhibitor and a therapeutic, either sequentially, in either order, or substantially simultaneously, can be more effective in treating cancer in some subjects and/or can initiate, enable, increase, enhance or prolong the activity and/or number of immune cells, or a medically beneficial response by a tumor.
Type: Application
Filed: March 25, 2024
Publication date: November 21, 2024
Applicants: Cognate Bioservices, Inc., Northwest Biotherapeutics, Inc., The Regents of the University of California, RevImmune, Inc.
Inventors: Marnix Leo Bosch, James Kelly Ganjei, Linda F. Powers, Linda M. Liau, Robert M. Prins

https://patents.justia.com/assignee/northwest-biotherapeutics-inc
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News